comparemela.com

Latest Breaking News On - Akoya biosciences company profile - Page 1 : comparemela.com

Akoya Biosciences, Inc. (NASDAQ:AKYA) CEO Brian Mckelligon Sells 7,500 Shares

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) CEO Brian Mckelligon sold 7,500 shares of the company’s stock in a transaction that occurred on Tuesday, June 11th. The stock was sold at an average price of $2.08, for a total value of $15,600.00. Following the transaction, the chief executive officer now directly owns 224,733 shares […]

United-states
America
Brian-mckelligon
Asia-pacific
Akoya-biosciences
Morgan-stanley
Polar-capital-holdings-plc
Akoya-biosciences-company-profile
Tower-research-capital
Schonfeld-strategic-advisors
Canaccord-genuity-group
Akoya-biosciences-inc

Akoya Biosciences, Inc. (NASDAQ:AKYA) Short Interest Up 11.5% in May

Akoya Biosciences, Inc. (NASDAQ:AKYA – Get Free Report) saw a significant increase in short interest in the month of May. As of May 15th, there was short interest totalling 1,160,000 shares, an increase of 11.5% from the April 30th total of 1,040,000 shares. Based on an average daily trading volume, of 276,300 shares, the days-to-cover […]

United-states
America
Asia-pacific
Akoya-biosciences
Brian-mckelligon
Jpmorgan-chase-co
Nasdaq
Parkman-healthcare-partners
Asset-management-inc
Silvercrest-asset-management-group
Kent-lake-capital
Akoya-biosciences-inc

Akoya Biosciences, Inc. (NASDAQ:AKYA) to Post Q2 2024 Earnings of ($0.28) Per Share, Capital One Financial Forecasts

Akoya Biosciences, Inc. (NASDAQ:AKYA – Free Report) – Stock analysts at Capital One Financial dropped their Q2 2024 earnings per share estimates for Akoya Biosciences in a research note issued on Monday, May 13th. Capital One Financial analyst T. Chiang now expects that the company will post earnings of ($0.28) per share for the quarter, […]

United-states
America
Brian-mckelligon
Akoya-bioscience
Asia-pacific
Akoya-biosciences
Asset-management-inc
Canaccord-genuity-group
Nisa-investment-advisors
York-mellon-corp
Akoya-biosciences-inc
Tower-research-capital

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00 by Analysts at Canaccord Genuity Group

Akoya Biosciences (NASDAQ:AKYA – Free Report) had its price objective cut by Canaccord Genuity Group from $10.00 to $6.00 in a report issued on Tuesday morning, Benzinga reports. They currently have a buy rating on the stock. A number of other brokerages have also recently weighed in on AKYA. BTIG Research dropped their price target […]

United-states
America
Asia-pacific
Brian-mckelligon
Akoya-biosciences
Canaccord-genuity-group
Akoya-biosciences-inc
Schonfeld-strategic-advisors
Akoya-biosciences-company-profile
Asset-management-inc
Tower-research-capital
York-mellon-corp

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00

Akoya Biosciences (NASDAQ:AKYA) Price Target Cut to $6.00
dailypolitical.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from dailypolitical.com Daily Mail and Mail on Sunday newspapers.

United-states
America
Brian-mckelligon
Akoya-biosciences
Asia-pacific
Akoya-biosciences-company-profile
Securities-exchange-commission
Nisa-investment-advisors
Schonfeld-strategic-advisors
Akoya-biosciences-inc
Kent-lake-capital
Polar-capital-holdings-plc

vimarsana © 2020. All Rights Reserved.